Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn's disease (CD), is a chronic, relapsing inflammatory disorder of the intestine driven by disruption of mucosal immune balance. In this context, mucosal inflammation, oxidative stress, and damage to the epithelial barrier reinforce one another and form a self-perpetuating cycle. Oral nanozymes that combine catalytic removal of reactive oxygen species with in vivo imaging readouts provide a potential platform for site-focused intervention and imaging-based evaluation of IBD. This review focuses on how oral nanozymes are designed to couple imaging and therapy and summarizes recent progress in two overarching directions: single-modality imaging-guided strategies and multimodal imaging-guided strategies. Within the single-modality group, current studies are discussed mainly as computed tomography (CT)-guided strategies and optical/photoacoustic (PA)-guided strategies according to their dominant signal-generation mechanisms. Multimodal imaging-guided strategies, by contrast, integrate structural and functional information on a single platform to support more informative preclinical assessment of IBD. This paper also discusses current limitations in oral delivery, characterization of enzyme-like activity, imaging assessment, and long-term biosafety, thereby outlining key design principles for the next generation of oral nanozymes for visual theranostics in IBD.
Early oxidative stress caused by titanium implants can impair osseointegration. Manganese dioxide (MnO2) nanozyme coatings have the potential to scavenge H2O2 and simultaneously generate O2 to alleviate hypoxia, but their activity is mostly static, and the ion release is detrimental. A nano-MnO2/Ti/P(VDF-TrFE) sandwich-structured composite was fabricated, and ferroelectric polarization was applied to preset a tunable surface potential. Kelvin probe force microscopy (KPFM) verified a presettable potential within ±500 mV. Steady-state kinetics confirmed an enhancement in overall catalytic efficiency (higher Vmax and lower Km). This translated to a faster initial decomposition rate at a low, physiologically relevant H2O2 concentration (300 μM). Correspondingly, under these oxidative stress conditions, cell survival in the polarized group was higher than that in the unpolarized group, indicating that the enhanced initial rate can have a positive effect in such conditions. Overall, this study demonstrates a proof-of-concept strategy to tune MnO2 nanozyme catalysis using a polarization-preset surface potential, targeting implantation-relevant ROS-rich conditions.
Surface morphology and electrical characteristics are key factors affecting cell–material interactions on electroactive polymer films, but their coupled effects remain unclear. In this study, P(VDF-TrFE) nanofiber-clustered films were fabricated using an anodic aluminum oxide (AAO) template-assisted molding method, and their surface electrical properties were subsequently tailored by corona poling. The nanofibrous structure was formed without substantially disrupting the characteristic polar β phase. Compared with the planar film, the water contact angle (WCA) of the nanofiber-clustered film increased from 74.8° to 132.5°, indicating markedly enhanced hydrophobicity. Furthermore, corona poling increased the magnitude of the piezoelectric coefficient (|d33|) and altered the surface potential state. Protein adsorption and cell studies further showed that polarized nanofiber-clustered surfaces exhibited greater protein adsorption, more extensive cell spreading, and higher CCK-8 signals and alkaline phosphatase (ALP) activity. These results indicate that the biological interfacial response of P(VDF-TrFE) films is regulated by surface morphology, wettability, and polarization-induced electrical characteristics. This work provides insight into the combined roles of nanofiber-clustered topography and electrical characteristics in regulating cell-material interactions on P(VDF-TrFE) surfaces.